Osiris Therapeutics, Inc. (NASDAQ: OSIR) today announced that it will report its financial results for fourth quarter and full year ended December 31, 2014, on Thursday, March 5, 2015. Lode Debrabandere, Ph.D., President and Chief Executive Officer, and Philip R. Jacoby, Jr., Chief Financial Officer, will provide a company update and discuss results via a webcast and conference call on Thursday, March 5, 2015, at 9:00 a.m. ET.
Help employers find you! Check out all the jobs and post your resume.
